Diabetes

A man from Yanji, China, inadvertently injected insulin with the needle cover on for a month. He only realized his mistake after watching an online video, discovering he had skipped the crucial step of removing the protective cap. Despite the improper administration, his blood sugar surprisingly decreased due to diet and exercise. This incident highlights the critical need for better patient education on proper injection techniques, as studies show over 50% of Chinese diabetic patients make similar errors. The story emphasizes the importance of reading instructions and seeking proper guidance to avoid ineffective treatment.

Innovent Biologics will present at the ADA’s 85th Scientific Sessions, unveiling research on its pipeline for metabolic disease. Key highlights include IBI3030, a novel anti-PCSK9 antibody conjugate, and promising results on mazdutide, a dual GCG/GLP-1 receptor agonist. Mazdutide data will focus on liver fat reduction, MASH and fibrosis improvement, and uric acid reduction. The presentation will feature results from preclinical studies and investigator-initiated trials, pointing to Innovent’s focus on innovative metabolic disease therapies.